tyrphostin ag 1024 has been researched along with Bone Cancer in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luk, F | 1 |
| Yu, Y | 1 |
| Walsh, WR | 1 |
| Yang, JL | 1 |
1 other study available for tyrphostin ag 1024 and Bone Cancer
| Article | Year |
|---|---|
IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Resista | 2011 |